Document is current

Any future updates will be listed below

Neutrophil–lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib

Crossref DOI link: https://doi.org/10.1007/s12032-014-0969-5

Published Online: 2014-05-04

Published Print: 2014-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark